Pfizer Inc.

38.00+0.2600+0.69%Vol 3 064 7621Y Perf -11.86%
Nov 22nd, 2019 10:20
BID37.99 ASK38.00
Open37.79 Previous Close37.74
Pre-Market37.78 After-Market-
 0.04 0.11%  - -%
Target Price
41.71 
Analyst Rating
Moderate Buy 2.11
Potential %
9.76 
Finscreener Ranking
★★+     47.39
Insiders Trans % 3/6/12 mo.
100/-91/-99 
Value Ranking
★★★     52.19
Insiders Value % 3/6/12 mo.
100/-97/-100 
Growth Ranking
★★★     51.16
Insiders Shares Cnt. % 3/6/12 mo.
100/-97/-100 
Income Ranking
★★★★     55.45
Market Cap (M)210 297 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
32.24 
Earnings Date
29th Oct 2019

Today's Price Range

37.6938.04

52W Range

33.9746.47

5 Year PE Ratio Range

8.7033.70

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
1.23%
1 Month
3.60%
3 Months
7.58%
6 Months
-10.12%
1 Year
-11.86%
3 Years
20.46%
5 Years
28.08%
10 Years
156.46%

TickerPriceChg.Chg.%
PFE38.000.26000.69
AAPL262.550.54000.21
GOOG1 300.96-0.3900-0.03
MSFT149.570.09000.06
XOM69.670.00000.00
WFC54.130.57001.06
JNJ138.061.62001.19
FB199.061.13000.57
GE11.680.15001.30
JPM130.951.02000.79
Earnings HistoryEstimateReportedSurprise %
Q03 20190.630.7519.05
Q02 20190.770.803.90
Q01 20190.770.8510.39
Q04 20180.630.641.59
Q03 20180.760.782.63
Q02 20180.750.818.00
Q01 20180.740.774.05
Q04 20170.560.6210.71
Earnings Per EndEstimateRevision %Trend
12/2019 QR0.565.66Positive
12/2019 QR0.53-7.02Negative
12/2019 FY2.965.71Positive
12/2020 FY2.583.20Positive
Next Report Date-
Estimated EPS Next Report0.63
Estimates Count4
EPS Growth Next 5 Years %3.80
Volume Overview
Volume3 064 762
Shares Outstanding (K)5 534 123
Trades Count8 474
Dollar Volume84 399 469
Avg. Volume23 180 795
Avg. Weekly Volume16 755 740
Avg. Monthly Volume20 545 135
Avg. Quarterly Volume19 206 699
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (44.44 %)
4 (40.00 %)
4 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (55.56 %)
6 (60.00 %)
6 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.11
Moderate Buy
2.20
Moderate Buy
2.20

Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drugs Enbrel and Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.

CEO: Albert Bourla

Teplephone: +1 212 733-2323

Address: 235 East 42nd Street, New York 10017, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

53%47%

Bearish Bullish

70%30%

Bearish Bullish

52%48%

News

Stocktwits